subcutaneous semaglutide Wegovy® Pen and Pill Information Semaglutide Weight Loss Treatment: GLP-1

For a GP to prescribe it in New Zealand, they must ensure: Prescribing it just to try (or outside of these rules) puts both the patient and provider at risk

This is what tells your body to keep its muscle even while you're losing weight

A healthcare provider can evaluate whether dual therapy aligns with your metabolic profile and weight loss targets

declares having received honoraria from AstraZeneca, Bayer Yakuhin, Boehringer Ingelheim Japan, Daiichi Sankyo, Eli Lilly Japan, Kowa, Mitsubishi Tanabe Pharma, Mochida Pharmaceutical, MSD, Novartis Pharma, Novo Nordisk Pharma, Ono Pharmaceutical, Otsuka and Tsumura

Both carry warnings about pancreatitis, gallbladder problems, and thyroid tumors (based on animal studies)

Limitations: Small sample size, phase 2 only